Tuberculosis patients living with HIV receiving antiretroviral therapy in Antigua and Barbuda
Antigua and Barbuda: Tuberculosis patients living with HIV receiving antiretroviral therapy was 0 patients in 2021. ◆ Volatile
Tuberculosis patients living with HIV receiving antiretroviral therapy in Antigua and Barbuda, 2003–2021
Source: Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Measured in patients.
Analysis
In 2021, tuberculosis patients living with hiv receiving antiretroviral therapy in Antigua and Barbuda stood at 0 patients. That is the lowest value across all 19 years on record.
Compared with earlier readings it is down 100.0% over ten years.
Over the whole period, tuberculosis patients living with hiv receiving antiretroviral therapy in Antigua and Barbuda peaked at 5 patients in 2010 and was at its lowest, 0 patients, in 2003.
Antigua and Barbuda ranks 141st of 183 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Tuberculosis patients living with HIV receiving antiretroviral therapy in Antigua and Barbuda, year by year
| Year | patients | Change |
|---|---|---|
| 2003 | 0 patients | — |
| 2004 | 2 patients | — |
| 2005 | 3 patients | +50.0% |
| 2006 | 3 patients | +0.0% |
| 2007 | 0 patients | -100.0% |
| 2008 | 0 patients | — |
| 2009 | 0 patients | — |
| 2010 | 5 patients | — |
| 2011 | 4 patients | -20.0% |
| 2012 | 2 patients | -50.0% |
| 2013 | 4 patients | +100.0% |
| 2014 | 1 patients | -75.0% |
| 2015 | 0 patients | -100.0% |
| 2016 | 0 patients | — |
| 2017 | 0 patients | — |
| 2018 | 0 patients | — |
| 2019 | 0 patients | — |
| 2020 | 0 patients | — |
| 2021 | 0 patients | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.14 patients | 0 patients | 3 patients | 7 |
| 2010s | 1.6 patients | 0 patients | 5 patients | 10 |
| 2020s | 0 patients | 0 patients | 0 patients | 2 |
Countries ranked near Antigua and Barbuda
- 141 American Samoa 0 patients
- 141 Andorra 0 patients compare
- 141 Anguilla 0 patients compare
- 141 Aruba 0 patients compare
- 141 Barbados 0 patients compare
- 141 Bermuda 0 patients compare
- 141 British Virgin Islands 0 patients compare
- 141 Bulgaria 0 patients compare
- 141 Cayman Islands 0 patients compare
- 141 Cook Islands 0 patients
- 141 Cyprus 0 patients compare
- 141 Dominica 0 patients compare
- 141 French Polynesia 0 patients compare
- 141 Grenada 0 patients compare
- 141 Iceland 0 patients compare
- 141 Jordan 0 patients compare
- 141 Kiribati 0 patients compare
- 141 Maldives 0 patients compare
- 141 Marshall Islands 0 patients compare
- 141 Micronesia, Federated States of 0 patients
- 141 Monaco 0 patients
- 141 Montenegro 0 patients compare
- 141 Montserrat 0 patients compare
- 141 Naoero 0 patients
- 141 New Caledonia 0 patients compare
- 141 Niue 0 patients
- 141 Korea, Democratic People's Republic of 0 patients
- 141 North Macedonia 0 patients compare
- 141 Palau 0 patients
- 141 Palestine, State of 0 patients
- 141 Puerto Rico 0 patients compare
- 141 Saint Kitts and Nevis 0 patients compare
- 141 Saint Lucia 0 patients compare
- 141 Samoa 0 patients
- 141 Slovenia 0 patients compare
- 141 Solomon Islands 0 patients compare
- 141 Tokelau 0 patients
- 141 Turks and Caicos Islands 0 patients compare
- 141 Tuvalu 0 patients
- 141 Vanuatu 0 patients
- 141 Wallis and Futuna 0 patients
- 141 Yemen 0 patients compare
More health data for Antigua and Barbuda
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0772 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,555 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1 deaths (2100)
- Population ages 15-19, male, annual growth rate 0.9715 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0353 units per person (2025)
- Population ages 20-24, female, annual growth rate -2.42 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0342 units per person (2025)
Frequently asked questions
- What is tuberculosis patients living with hiv receiving antiretroviral therapy in Antigua and Barbuda?
- Tuberculosis patients living with hiv receiving antiretroviral therapy in Antigua and Barbuda was 0 patients in 2021, according to Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data.
- What is the highest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Antigua and Barbuda?
- The highest recorded value was 5 patients in 2010.
- What is the lowest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Antigua and Barbuda?
- The lowest recorded value was 0 patients in 2003.
- How does Antigua and Barbuda rank for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Antigua and Barbuda ranks 141st out of 183 countries with data for 2021.
- Is tuberculosis patients living with hiv receiving antiretroviral therapy rising or falling in Antigua and Barbuda?
- Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
- Where does this Antigua and Barbuda data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as part of Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.